Skip to main content
. Author manuscript; available in PMC: 2010 Nov 22.
Published in final edited form as: Curr Top Med Chem. 2009;9(13):1181–1193. doi: 10.2174/156802609789753644

Table 1.

PDE isoform selectivity data for rolipram and NCGC116

PDE isoform* rolipram IC50/% inh. 6 IC50/% inh.
graphic file with name nihms246712t1.jpg
rolipram
PDE1A inactive inactive
PDE1B inactive inactive
PDE1C inactive 26%
PDE2A inactive 41%
graphic file with name nihms246712t2.jpg
6 (NCGC00165289)
PDE3A inactive 1.7 μM
PDE3B inactive 720 nM
PDE4A1A 102 nM 12.9 nM
PDE4B1 901 nM 48.2 nM
PDE4B2 534 nM 37.2 nM
PDE4C1 40% 452 nM
PDE4D2 403 nM 49.2 nM
PDE5A1 inactive 60%
PDE7A inactive 73%
PDE7B inactive 33%
PDE8A1 inactive 57%
PDE9A2 inactive inactive
PDE10A1 inactive 823 nM
PDE11A4 inactive inactive
*

data generated by BPS Biosciences (CA) [http://www.bpsbioscience.com] and represents either the IC50 value or the % inhibition at 10 uM of compound.